InsidersTradesSigma
拓新药业 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 拓新药业 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 拓新药业 has logged 10 reports. Market capitalisation: €3.5bn. The latest transaction was filed on 23 February 2023 (Sale). Among the most active insiders: 蔡玉瑛. Every trade is accessible without an account.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
10 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,452 of 25,688 companies
24.6
score / 100
Value27
Quality23
FCF yld-2.5%
Earn yld-2.5%
EV/EBITDA·
ROE-5.1%
Gross mgn26%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 February 2023
Declarations10 total
10 of 10 declarations